British opponents of gene patenting this week exposed deals that give a
tobacco company exclusive rights to develop and sell vaccines against lung
cancer. “It’s cynical for tobacco companies to profit from diseases that their
own products cause,” says Helen Wallace of GeneWatch. The pressure group
highlights two deals struck by Japan Tobacco, which makes three of the world’s
five top-selling cigarette brands. In one deal, Corixa of Seattle, Washington,
granted Japan Tobacco a licence to develop vaccines based on patented genes that
are uniquely active in lung cancer cells.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
2
Photos reveal unexpected details from the world's first atomic test
3
The ‘doomsday’ glacier’s giant ice shelf is about to break away
4
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
5
What is love? Even a meeting on the subject can't find the answer
6
How I used psychology to come back from the worst year of my life
7
Mystery of the ancient giant stone jars of Laos may have been solved
8
The distant world that is our best hope of finding alien life
9
The hidden pockets of the universe where the future can cause the past
10
Epic dreaming is leaving people exhausted and distressed
